Literature DB >> 19789011

The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.

Anton I Skaro1, Colleen L Jay, Talia B Baker, Edward Wang, Sarina Pasricha, Vadim Lyuksemburg, John A Martin, Joseph M Feinglass, Luke B Preczewski, Michael M Abecassis.   

Abstract

BACKGROUND: Liver transplantation (LT) from donation after cardiac death (DCD) donors is increasingly being used to address organ shortages. Despite encouraging reports, standard survival metrics have overestimated the effectiveness of DCD livers. We examined the mode, kinetics, and predictors of organ failure and resource utilization to more fully characterize outcomes after DCD LT.
METHODS: We reviewed the outcomes for 32 DCD and 237 donation after brain death (DBD) LT recipients at our institution.
RESULTS: Recipients of DCD livers had a 2.1 times greater risk of graft failure, a 2.5 times greater risk of relisting, and a 3.2 times greater risk of retransplantation compared with DBD recipients. DCD recipients had a 31.6% higher incidence of biliary complications and a 35.8% higher incidence of ischemic cholangiopathy. Ischemic cholangiography was primarily implicated in the higher risk of graft failure observed after DCD LT. DCD recipients with ischemic cholangiography experienced more frequent rehospitalizations, longer hospital stays, and required more invasive biliary procedures.
CONCLUSION: Related to higher complication rates, DCD recipients necessitated greater resource utilization. This more granular data should be considered in the decision to promote DCD LT. Modification of liver allocation policy is necessary to address those disadvantaged by a failing DCD graft.

Entities:  

Mesh:

Year:  2009        PMID: 19789011      PMCID: PMC2790600          DOI: 10.1016/j.surg.2009.06.052

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

1.  Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.

Authors:  R Mateo; Y Cho; G Singh; M Stapfer; J Donovan; J Kahn; T-L Fong; L Sher; N Jabbour; S Aswad; R R Selby; Y Genyk
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

2.  Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.

Authors:  Z A Stewart; A M Cameron; A L Singer; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2008-11-27       Impact factor: 8.086

3.  Donation after cardiac death: the University of Wisconsin experience with liver transplantation.

Authors:  David P Foley; Luis A Fernandez; Glen Leverson; L Thomas Chin; Nancy Krieger; Jeffery T Cooper; Brian D Shames; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Hans W Sollinger; Munci Kalayoglu; Anthony M D'Alessandro
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

4.  Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update.

Authors:  D J Reich; S J Munoz; K D Rothstein; H M Nathan; J M Edwards; R D Hasz; C Y Manzarbeitia
Journal:  Transplantation       Date:  2000-10-27       Impact factor: 4.939

5.  Survival following liver transplantation from non-heart-beating donors.

Authors:  Peter L Abt; Niraj M Desai; Michael D Crawford; Lisa M Forman; Joseph W Markmann; Kim M Olthoff; James F Markmann
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

6.  Successful extrarenal transplantation from non-heart-beating donors.

Authors:  A M D'Alessandro; R M Hoffmann; S J Knechtle; D E Eckhoff; R B Love; M Kalayoglu; H W Sollinger; F O Belzer
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

7.  Characteristics associated with liver graft failure: the concept of a donor risk index.

Authors:  S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

8.  Donation after cardiac death: the University of Wisconsin experience.

Authors:  Anthony M D'Alessandro; Luis A Fernandez; L Thomas Chin; Brian D Shames; Nicole A Turgeon; David L Scott; Antonio Di Carlo; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Robert B Love; John D Pirsch; Bryan N Becker; Alexandru I Musat; Munci Kalayoglu; Hans W Sollinger
Journal:  Ann Transplant       Date:  2004       Impact factor: 1.530

9.  Long-term outcome of controlled, non-heart-beating donor liver transplantation.

Authors:  Cosme Y Manzarbeitia; Jorge A Ortiz; Hoonbae Jeon; Kenneth D Rothstein; Oscar Martinez; Victor R Araya; Santiago J Munoz; David J Reich
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

10.  Experience with liver and kidney allografts from non-heart-beating donors.

Authors:  A Casavilla; C Ramirez; R Shapiro; D Nghiem; K Miracle; O Bronsther; P Randhawa; B Broznick; J J Fung; T Starzl
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

View more
  38 in total

1.  Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit.

Authors:  Colleen L Jay; Anton I Skaro; Daniela P Ladner; Edward Wang; Vadim Lyuksemburg; Yaojen Chang; Hongmei Xu; Sandhya Talakokkla; Neehar Parikh; Jane L Holl; Gordon B Hazen; Michael M Abecassis
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

2.  Donation after cardiac death: a 29-year experience.

Authors:  Janet M Bellingham; Chandrasekar Santhanakrishnan; Nikole Neidlinger; Philip Wai; Jim Kim; Silke Niederhaus; Glen E Leverson; Luis A Fernandez; David P Foley; Joshua D Mezrich; Jon S Odorico; Robert B Love; Nilto De Oliveira; Hans W Sollinger; Anthony M D'Alessandro
Journal:  Surgery       Date:  2011-10       Impact factor: 3.982

3.  Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.

Authors:  Kristopher P Croome; Amit K Mathur; David D Lee; Adyr A Moss; Charles B Rosen; Julie K Heimbach; C Burcin Taner
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 4.  Donations After Circulatory Death in Liver Transplant.

Authors:  Emre A Eren; Nicholas Latchana; Eliza Beal; Don Hayes; Bryan Whitson; Sylvester M Black
Journal:  Exp Clin Transplant       Date:  2016-10       Impact factor: 0.945

Review 5.  Potential approaches to improve the outcomes of donation after cardiac death liver grafts.

Authors:  Paria Mahboub; Adel Bozorgzadeh; Paulo N Martins
Journal:  World J Transplant       Date:  2016-06-24

Review 6.  Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.

Authors:  Seth J Karp; Scott Johnson; Amy Evenson; Michael P Curry; Diarmuid Manning; Raza Malik; Gerond Lake-Bakaar; Michelle Lai; Douglas Hanto
Journal:  HPB (Oxford)       Date:  2011-04-04       Impact factor: 3.647

7.  Superior survival using living donors and donor-recipient matching using a novel living donor risk index.

Authors:  David S Goldberg; Benjamin French; Peter L Abt; Kim Olthoff; Abraham Shaked
Journal:  Hepatology       Date:  2014-10-02       Impact factor: 17.425

8.  Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience

Authors:  Kerollos Wanis
Journal:  Can J Surg       Date:  2019-02-01       Impact factor: 2.089

9.  Dual chamber stent prevents organ malperfusion in a model of donation after cardiac death.

Authors:  Bryan W Tillman; Youngjae Chun; Sung Kwon Cho; Yanfei Chen; Nathan Liang; Timothy Maul; Anthony Demetris; Xinzhu Gu; William R Wagner; Amit D Tevar
Journal:  Surgery       Date:  2016-08-11       Impact factor: 3.982

10.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.